Royal Bank of Canada
AURA icon

Royal Bank of Canada’s Aura Biosciences AURA Stock Holding History

Royal Bank of Canada’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9K Sell
1,380
-1,683
-55% -$9.66K ﹤0.01% 6186
2025
Q4 		$17K Sell
3,063
-39,472
-93% -$234K ﹤0.01% 6131
2025
Q3 		$263K Buy
42,535
+3,903
+10% +$25.5K ﹤0.01% 4912
2025
Q2 		$242K Buy
38,632
+33,689
+682% +$197K ﹤0.01% 5011
2025
Q1 		$29K Sell
4,943
-12,596
-72% -$95.3K ﹤0.01% 5784
2024
Q4 		$144K Buy
17,539
+11,799
+206% +$111K ﹤0.01% 5084
2024
Q3 		$50K Buy
5,740
+524
+10% +$4.49K ﹤0.01% 5697
2024
Q2 		$39K Buy
5,216
+3,562
+215% +$26.1K ﹤0.01% 5765
2024
Q1 		$13K Sell
1,654
-8,802
-84% -$73K ﹤0.01% 6086
2023
Q4 		$92K Buy
10,456
+5,004
+92% +$42.4K ﹤0.01% 5663
2023
Q3 		$49K Buy
5,452
+1,586
+41% +$17.1K ﹤0.01% 5791
2023
Q2 		$47K Buy
3,866
+2,543
+192% +$27.2K ﹤0.01% 5806
2023
Q1 		$12K Sell
1,323
-1,358
-51% -$14.1K ﹤0.01% 6226
2022
Q4 		$28K Buy
2,681
+2,458
+1,102% +$31.3K ﹤0.01% 6155
2022
Q3 		$4K Buy
223
+120
+117% +$1.82K ﹤0.01% 6792
2022
Q2 		$1K Sell
103
-242
-70% -$4K ﹤0.01% 7085
2022
Q1 		$8K Sell
345
-813
-70% -$15.5K ﹤0.01% 7038
2021
Q4 		$19K Buy
+1,158
New +$20.7K ﹤0.01% 6822

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Royal Bank of Canada's AURA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Aura Biosciences (AURA) stake by 55% in Q1 2026, selling an estimated $9.66K and leaving 1,380 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #6186.

Royal Bank of Canada first reported a position in AURA in Q4 2021 and has held it in 18 quarters since. The position peaked at $263K in Q3 2025. 126 funds tracked by Wall St. Rank hold AURA as of Q1 2026.

  • Royal Bank of Canada held 1,380 shares of Aura Biosciences worth $9K as of Q1 2026.
  • Royal Bank of Canada sold 1,683 Aura Biosciences shares in Q1 2026, an estimated $9.66K.
  • Aura Biosciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6186 holding.
  • Royal Bank of Canada first reported a position in Aura Biosciences in Q4 2021 and has held it in 18 quarters since.
  • Royal Bank of Canada's Aura Biosciences position peaked at $263K in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Aura Biosciences as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.